Genomic Medicine Strategy Plan 2021-2030

This Strategy Plan describes what GMS aims to accomplish within the next-coming 10 years as well as the key issues that needs to be adressed and handled in order for precision medicine to be implemented successfully in Swedish healthcare.

The Strategy Plan has been produced by GMS management group and steering committee, in dialogue with the Swedish Life Science Office.